Skip to main content
. 2024 May 23;120:109789. doi: 10.1016/j.ijscr.2024.109789

Fig. 3.

Fig. 3

Survival curves (log rank) of patients at the period of malignant melanoma metastasizes to the bladder. (A) Survival curve of period of the metastatic melanoma to bladder. (B) Survival of patients with synchronous vs without synchronous metastases. (B) Patients with metachronous vs non-metachronous metastases. The Log-rank test of Figs. B & C indicate that there were the significant differences between the couple of survival curves (p < 0.05).